Pharmaceutical News

RSS

Stopping opioid addiction at one key source: The hospital

It may not be rocket science, but a group of surgeons at the University of Michigan's Michigan Medicine have devised a strategy to curb the nation's opioid epidemic — starting at their own hospital.

6 Dec 2017

Researchers identify risk factor for drug-induced skin disease in diabetic patients

Researchers have identified a type of human leukocyte antigen (HLA) that is associated with the skin disease bullous pemphigoid (BP) in diabetic patients administered with DPP-4 inhibitory drugs.

6 Dec 2017

BU researchers receive $2.7 million grant to find better ways of delivering anti-retrovirals

Rahm Gummuluru, PhD, associate professor of microbiology at Boston University School of Medicine, and Bjoern Reinhard, PhD, professor of chemistry at Boston University, have been awarded a Research Project Grant from the National Institutes of Allergy and Infectious Diseases/National Institute of Health.

5 Dec 2017

Study shows connection between common hypertension drug and skin cancer

Recently published research from The University of Southern Denmark and the Danish Cancer Society shows a connection between one of the most common medications for hypertension and skin cancer.

4 Dec 2017

Malvern Panalytical Announce Efforts Towards a Platform For Protein Aggregation Profiling

Malvern Panalytical announces the launch of a collaborative project which aims to support the development of existing and next generation biopharmaceutical products.

From Malvern Panalytical 4 Dec 2017

Study: Doctors may prescribe double the number of opioids than what patient needs after hysterectomy

Doctors may be prescribing nearly twice the number of opioids than what the average patient needs after a hysterectomy, a new study suggests.

4 Dec 2017

FDA grants approval to first biosimilar for treatment of patients with breast, stomach cancers

The U.S. Food and Drug Administration today approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients with breast or metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma) whose tumors overexpress the HER2 gene (HER2+).

4 Dec 2017

Less than one-third of glaucoma patients talk to their doctor about medication costs, study finds

Less than one-third of patients with glaucoma talk to their doctor about the costs of medications needed to control their disease, reports a study in the December issue of Optometry and Vision Science, the official journal of the American Academy of Optometry.

4 Dec 2017

Optimal measurement with new Sens-o-Spheres

Bio-reactors are the cooking pots of biochemists and bio-technologists, in which pharmaceutical agents, enzymes or nematodes are produced for the purpose of biological pest control.

1 Dec 2017

Guidelines to control opioid prescribing for post-surgery pain

A recent study, conducted at Dartmouth-Hitchcock Medical Center in Lebanon, NH, suggests that more vigilant prescribing guidelines could reduce the number of opioid pills a patient receives after surgery, whilst still meeting pain management needs.

1 Dec 2017

Orchard Therapeutics opens new facility for technical operations in San Francisco Bay area

Orchard Therapeutics, a clinical-stage biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies, today announced the opening of a second facility for technical operations in the San Francisco Bay Area.

1 Dec 2017

Guideline for surgeons could reduce opioids prescribed after operations by 40%

Rising rates of opioid prescriptions have been linked to the opioid epidemic, and a significant number of opioid deaths have been linked to prescriptions written by surgeons.

1 Dec 2017

New drugs Erenumab and Fremanezumab show promise for migraine

Migraine headaches affect thousands of Americans and millions worldwide. There are several medications that are being prescribed for migraines and for many these do not work well.

30 Nov 2017

Novel drug combination could enhance immunotherapy responses in patients with lung cancer

Johns Hopkins Kimmel Cancer Center researchers and colleagues have identified a novel drug combination therapy that could prime nonsmall cell lung cancers to respond better to immunotherapy.

30 Nov 2017

Drug that stimulates neuron pruning promotes goal-directed behavior in mice

A drug that stimulates neuron pruning can nudge mice away from habit-driven behaviors when combined with retraining, neuroscientists have found.

30 Nov 2017

Development of unique hemostatic agent nearing completion

The development of the unique agent called Tectum, which accelerates blood coagulation in a matter of seconds, is nearing completion: scientists of Lobachevsky University are planning to launch in Nizhny Novgorod the production of this unique means for stopping bleeding.

30 Nov 2017

Pharmaceutical News

Stopping opioid addiction at one key source: The hospital

Researchers identify risk factor for drug-induced skin disease in diabetic patients

BU researchers receive $2.7 million grant to find better ways of delivering anti-retrovirals

Study shows connection between common hypertension drug and skin cancer

Malvern Panalytical Announce Efforts Towards a Platform For Protein Aggregation Profiling

Study: Doctors may prescribe double the number of opioids than what patient needs after hysterectomy

FDA grants approval to first biosimilar for treatment of patients with breast, stomach cancers

Less than one-third of glaucoma patients talk to their doctor about medication costs, study finds

Optimal measurement with new Sens-o-Spheres

Guidelines to control opioid prescribing for post-surgery pain

Orchard Therapeutics opens new facility for technical operations in San Francisco Bay area

Guideline for surgeons could reduce opioids prescribed after operations by 40%

New drugs Erenumab and Fremanezumab show promise for migraine

Novel drug combination could enhance immunotherapy responses in patients with lung cancer

Drug that stimulates neuron pruning promotes goal-directed behavior in mice

Development of unique hemostatic agent nearing completion

Altering genetic mutation could enhance FluMist vaccine’s protective effect

Patients with rare diseases and congress square off over orphan drug tax credits

Study focuses on improving pharmacokinetic properties of therapeutic aptamers

AIDA project optimizes use of old antibiotics for better patient care

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Latest News